Published on October 19, 2017
Dr Neal Shore, Director, CPI, Carolina Urologic Research Center, give us an update on the latest treatment options for prostate cancer patients with metastatic disease. Since 2010 there has been an explosion of new treatments that offer hope and give a better quality of life to patients.
This interview is part of an educational program by the Patient Empowerment Foundation (PEF). We thank Bayer for their support.